Skip to content

Inspection Record

CD Pharmacy LLC dba Red Rock Pharmacy — FDA 483 Findings

US FDAInspected 2026-07-31Published 2026-09-10 9 findingsAseptic processing and sterility assuranceOther quality systemMaterial and supplier controlContamination control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Failure to conduct media fills that closely simulate aseptic production operations under the worst-case, most-challenging, and stressfol conditions.

2Aseptic processing and sterility assurance

Personnel were observed touching equipment or other surfaces located outside of the ISO S area with gloved hands and then proceeding with aseptic processing without changing or sanitizing gloves.

3Other quality system

Hazardous drugs were produced without providing adequate containment.

4Other quality system

Your firm released drug product in which the strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.

5Aseptic processing and sterility assurance

Smoke studies were inadequately perfomed under dynamic conditions.

6Material and supplier control

Materials were exposed to lower than ISO 5 quality air.

7Aseptic processing and sterility assurance

Personnel were observed conducting aseptic manipulations where the movement of"first air" in tHE ISO 5 area is blocked or disrupted.

8Contamination control

Personnel inadequately sanitized gloves to prevent contamination.

9Other quality system

Inadequate post-use filter-integrity testing on filters used to sterilize drug products.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-09-10. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

CD Pharmacy LLC dba Red Rock Pharmacy company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.